Nyxoah operates within the specialized medical device sector focused on neurostimulation treatments for obstructive sleep apnea, competing directly against industry pioneers and alternative therapeutic developers. Its most prominent market competitor is Inspire Medical Systems, which manufactures the widely adopted FDA-approved Inspire hypoglossal nerve stimulation system, alongside other emerging surgical and non-invasive sleep disorder treatment providers.